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Background. Aggressive angiomyxoma is a rare soft tissue tumour that carries a high risk of local relapse. It is a slowly growing and
locally infiltrating tumour.
Case. We describe the case of an aggressive pelvic-perineal angiomyxoma arising in a 36-year-old woman. The patient had a mass that
grew before, during and after her pregnancy. Transperineal surgery was performed. The resection margins were free of disease.
Conclusion. Our case confirms what has previously been published concerning the possible hormone-dependence of this neoplasm.
Given the positive estrogen and progesterone receptor status of this tumour, we will consider hormonal treatments in the case of a future
relapse.
D 2004 Published by Elsevier Inc.
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Aggressive angiomyxoma is a rare soft tissue tumour that
carries a high risk of local relapse [1]. About 150 cases have
been published in the literature since 1983, when it was first
described by Steeper and Rosai [3] as a slowly growing
myxoid neoplasm [2]. It almost exclusively involves the
genital, perineal and pelvic regions of women of child-
bearing age and has its median incidence in the fourth
decade [1]. However, there have also been rare cases
diagnosed in perimenopausal women, men and children, and
it has been found not only in the pelvic soft tissue, but also
in the retroperitoneum, vesica, vagina, vulva, perineum and
scrotum [4]. It is a slowly growing and locally infiltrating0090-8258/$ - see front matter D 2004 Published by Elsevier Inc.
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cases, often appear many years (sometimes decades) after
the first excision [1]. The literature also includes two cases
diagnosed in pregnant women and a third relapsing during
pregnancy [5].Case report
We here report the case of an aggressive pelvic-perineal
angiomyxoma arising in a 36-year-old woman (VB), whose
recent and remote medical history included no diseases
worthy of note. She had only one at time pregnancy. Her
body weight increased all through the pregnancy 15 kg. She
underwent a cesarean section because of a breech presenta-
tion in January 2002. She noted a small mass at the level of
the right labium majus, which grew extremely slowly before
and during the pregnancy, but very rapidly after the birth.
For this reason, she underwent surgical excision of the
nodule (a suspected lipoma) on August 5, 2003. Unexpect-
edly, the histological diagnosis of the excised mass (a 10 g95 (2004) 724–728
R. Ribaldone et al. / Gynecologic Oncology 95 (2004) 724–728 725oval nodule with a maximum diameter of 4.5 cm) was
aggressive angiomyxoma.
Further diagnostic investigations were carried out,
including nuclear magnetic resonance (NMR) and computed
tomography (CT). NMR revealed a mass with a maximumFig. 1. CT of the pelvis (A) revealed the presence of a solid formation characteris
between the internal obturator and levator muscles of the anus. Transperineal ech
poorly defined margins; colour-Doppler demonstrated irregular, thin and randomldiameter of 6.5 cm in the adipose tissue on the right side of
the pelvic fossa, between the obturator and levator muscles
of the anus, extending towards the right side of the
perineum. The examination also showed a limited disloca-
tion of the ampulla of the rectum, the involvement of theed by uneven late contrast enhancement on the right, in the adipose tissue
ography (B) revealed an ovoid mass with a homogeneous echotexture and
y dispersed vessels in the central area of the tumour.
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labium majus.
Contrast CT of the pelvis revealed the presence of a solid
formation characterised by uneven late contrast enhance-
ment on the right, in the adipose tissue between the internal
obturator and levator muscles of the anus. This formation
was 6.5 cm long cranio-caudally, extended into the perineal
adipose tissue of the medial region of the thigh and then
seemed to be displaced contralaterally and infiltrate the right
lateral wall of the vagina and the homolateral labium majus
(Fig. 1A).
Transperineal echography did not show any infiltration
of the perineal muscles; transperineal ultrasonography
revealed an ovoid mass with a homogeneous echotexture
and poorly defined margins; colour-Doppler demonstrated
irregular, thin and randomly dispersed vessels in the central
area of the tumour (Fig. 1B).
A gynecological examination performed in December
2003 revealed an uninfiltrated vaginal wall, a soft and
relatively immobile neoplasm with a diameter of about 8 cm
that did not reach the upper part of the ischio-rectal fossa
and a rectal wall that was neither infiltrated nor dislocated.
This finding was confirmed by a transperineal echogram
taken during the second admission.
For this reason, transperineal surgery was performed on
December 2, 2003. A right peri-labial incision was made
and the neoplasm was removed after an external sphincter-
otomy; the fossa was drained and the external anal sphincter
was reconstructed (Fig. 2). The postoperative course was
uneventful.
Upon macroscopic examination, the tumour was a 40 g
grey-pink, lobulated and poorly circumscribed mass with aFig. 2. A right peri-labial incision was made and the neoplasm was enucleated af
sphincter was reconstructed.maximum diameter of about 15 cm. When sectioned, the
surface had a soft, myxoid appearance with irregular
borders.
The tumour was fixed in buffered formalin for 48 h and
extensively sampled. After fixation, small samples were
embedded in paraffin and routinely processed for histologic
examination and immunohistochemistry.
Histological staining included hematoxylin–eosin (H&E),
Masson’s trichrome and Gomori’s method for reticular fibres.
The sections were also immunostained for vimentine, S100,
smooth-muscle specific actin (SM-actin), desmin, CD 34,
Mib 1 and estrogen and progesterone receptors.
Vimentine (Immunotech, Marseille, France, dilution
1:50)
Actin (DAKO, Carpinteria, CA, USA, dilution 1:100)
S100 (Biogenex, San Ramon, CA, USA, dilution 1:50)
Desmin (Biogenex, dilution 1:40)
CD 34 (Neo markers, Fremont, CA, USA, dilution 1:60)
Mib 1 (Immunotech, dilution 1:100)
Estrogen (DAKO, dilution 1:35)
Progesterone (DAKO, dilution 1:50)
H&E staining showed that the neoplasm was paucicellular
and consisted of small, spindle-shaped cells with a poorly
defined eosinophilic cytoplasm and bland nuclei. These were
merged in an abundant myxoid and edematous stroma con-
taining medium-sized to large vessels with thick and occa-
sionally hyalinised walls (Fig. 3A). The neoplastic cells were
frequently clustered around the vessels in a whorl fashion.
Despite a careful search, no mitotic figures were
identified.ter an external sphincterotomy; the fossa was drained and the external anal
Fig. 3. Micrographs of neoplastic histologic sections: (A) on H&E examination a cluster of medium-sized arterioles are in close contact with spindle-shaped
neoplastic cells, that (B) strongly stained with anti-SM actin antiserum. (original magnification 200).
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epithelial duct of Bartholin’s gland and neural elements
although surgical margins, identified as burned tissue,
were pathologically negative.
Immunohistochemistry revealed strong positivity for
vimentin, SM actin and desmin, whereas S100 and CD34
were negative (Fig. 3B). Estrogen and progesterone
antisera disclosed positively stained nuclei in about
90% of neoplastic cells.
On the basis of these findings, a diagnosis of deep
(aggressive) angiomyxoma was formulated. The main
differential diagnoses included myxoid neoplasms (myx-
oid neurofibroma, low grade myxofibrosarcoma, myxoid
liposarcoma, myxoid malignant fibrous histocytoma and
superficial angiomyxoma), cellular angiofibroma, angio-myofibroblastoma and benign conditions such as chronic
fibrosis or edema of the labia.Discussion
Rosai and Steeper [3] first described a very slowly
growing myxoid neoplasm of the genitals and perineal and
pelvic region in 1983.
The pathogenesis of aggressive angiomyxoma is not clear.
Recent studies have demonstrated a translocation at the level
of chromosome 12 with a consequent aberrant expression of
the HMGIC protein involved in DNA transcription [1].
The diagnosis of aggressive angiomyxoma is not usually
made by the clinician, but by the pathologist. The most
R. Ribaldone et al. / Gynecologic Oncology 95 (2004) 724–728728frequent clinical diagnoses include Bartholin’s cyst, labial
cyst, polyp, Gartner’s duct cyst, pedunculated soft tissue
tumours or perineal herniation. In the case we report, the
initial diagnosis was vulvar lipoma [5].
The sizes of the neoplasms described in the literature
vary from 5 to 23 cm [6].
The largest (giant) aggressive myxoma was described in
1998 by Chen, who published a case report concerning a 38-
year-old woman with a mass of 57  47  23 cm that had
developed slowly over about 8 years, but particularly during
pregnancy [7].
Our patient had a mass that grew extremely slowly before
and during her pregnancy, but very rapidly after the birth of
the fetus. This was probably due to the fact that patient’s
body weight increased significantly during the pregnancy
(15 kg) and so the soft tissue’s expansion masked the
tumour growth.
The immunohistochemical study of our case revealed
positive estrogen and progesterone receptors, with negative
proliferative index (Mib1) indicating a low rate of
proliferation.
Fishman et al. [8] described a case of a 37-year-old
woman with a diagnosis of aggressive angiomyxoma who
was weakly estrogen-positive and progesterone-negative,
and relapsed during pregnancy. On the other hand, Htwe et
al. [9] found that a 41-year-old woman diagnosed as having
aggressive angiomyxoma during pregnancy with positive
progesterone receptors and negative estrogen receptors.
As described in previous case reports, this tumour
frequently requires a combined abdomino-perineal approach
[7]. After the histological diagnosis of the first surgical
excision, several investigations were undertaken to evaluate
the topography of the tumour more precisely with the aim of
making a complete but as conservative an excision as
possible with the second operation, given the young age of
the patient.
The right perilabial incision allowed confirmation of the
clinical and echographic findings, and so, as there was a
clear cleavage between the neoplasm and the levator muscle
of the anus, perineal access was sufficient.
The resection margins were free of disease.
Given the topographical variability of this genital
tumour, no standardised surgical procedure has been
described in the literature, but all of the authors haveunderlined the importance of the complete eradication of the
disease.
Positive lesion margins are certainly a very important
factor when considering the possibility of relapse because of
the local infiltration capacity of the tumour, even though a
broad resection with tumour-free margins does not totally
prevent a recurrence [4].
It has been reported that a recurrent aggressive angio-
myxoma can be treated using GnRH agonists, which leads
to NMR-detected disease remission and makes it possible to
avoid further destructive surgery [4,10]. Given the positive
estrogen and progesterone receptor status of the tumour here
described, we consider hormonal treatments in the case of a
future relapse.References
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